GPC Draws $10M Up Front In Japanese Marketing Deal June 26, 2007 One month away from an FDA panel review, GPC Biotech Inc.'s satraplatin for prostate cancer has become the subject of a $10 million license deal with Yakult Honsha Co. Ltd., for rights in Japan. (BioWorld Today)Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: May 18 - June 20, 2007 June 25, 2007
RSS